US FDA Approves Revolutionary Postpartum Depression Pill – Zurzuvae Offers Hope for New Mothers

US FDA Approves Postpartum Depression Pill

In a historic breakthrough, the Food and Drug Administration (FDA) in the US has granted approval for the first-ever pill designed to combat postpartum depression (PPD). Marketed under the name Zurzuvae, the innovative zuranolone pill provides a convenient once-daily dosage regimen over a two-week period. Previously, PPD treatment options were limited to intravenous injections, but … Read more

FDA Approves Groundbreaking Nonprescription Daily Oral Contraceptive

FDA Approves Opill, the First Nonprescription Daily Oral Contraceptive in the U.S. The U.S. Food and Drug Administration (FDA) has granted approval for Opill (norgestrel) tablet to be available without a prescription, making it the first daily oral contraceptive that can be purchased directly by consumers. This significant development provides individuals with the option to … Read more